Abstract Nav1.6 and Nav1.6-mediated resurgent currents have been implicated in several pain pathologies. However, our knowledge of how fast resurgent currents are modulated in neurons is limited. Our study explored the potential regulation of Nav1.6-mediated resurgent currents by isoforms of fibroblast growth factor homologous factor 2 (FHF2) in an effort to address the gap in our knowledge. FHF2 isoforms colocalize with Nav1.6 in peripheral sensory neurons. Cell line studies suggest that these proteins differentially regulate inactivation. In particular, FHF2A mediates long-term inactivation, a mechanism proposed to compete with the open-channel blocker mechanism that mediates resurgent currents. On the other hand, FHF2B lacks the ability to mediate long-term inactivation and may delay inactivation favoring openchannel block. Based on these observations, we hypothesized that FHF2A limits resurgent currents, whereas FHF2B enhances resurgent currents. Overall, our results suggest that FHF2A negatively regulates fast resurgent current by enhancing long-term inactivation and delaying recovery. In contrast, FHF2B positively regulated resurgent current and did not alter long-term inactivation. Chimeric constructs of FHF2A and Navβ4 (likely the endogenous open channel blocker in sensory neurons) exhibited differential effects on resurgent currents, suggesting that specific regions within FHF2A and Navβ4 have important regulatory functions. Our data also indicate that FHFAs and FHF2B isoform expression are differentially regulated in a radicular pain model and that associated neuronal hyperexcitability is substantially attenuated by a FHFA peptide. As such, these findings suggest that FHF2A and FHF2B regulate resurgent current in sensory neurons and may contribute to hyperexcitability associated with some pain pathologies.
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Introduction
Voltage-gated sodium channels (VGSCs) selectively mediate the inward flow of sodium ions generating the rapid upstroke of the action potential [26, 41] . As such, alteration of sodium channel activity can be an underlying mechanism in neurological pathologies [31] including, but not limited to, pain [8, 10, 12, 61] . Painful sensations can commonly arise from increased firing of peripheral sensory neurons in dorsal root ganglia (DRG) and trigeminal ganglia [49] . Adult DRG neurons normally express a variety of VGSC isoforms that can be distinguished based on their sensitivity to tetrodotoxin (TTX) inhibition resulting in two classes: TTX-sensitive (TTXS: Nav1.1, 1.6, Nav1.7) and TTX-resistant (TTXR: Nav1.8 and Nav1.9) channels [4, [13] [14] [15] 25] . Some of these VGSC isoforms can generate an unusual current known as resurgent current [6, 22, 28, 44, 55] . Resurgent currents are generated when VGSCs open (upon membrane depolarization) and an open-channel blocker out-competes the intrinsic mechanism of inactivation (fast inactivation) and blocks the channels in the open conformation [1, 21, 34] . This open channel block mechanism temporarily terminates further sodium influx because as the membrane repolarizes, the blocker unbinds and sodium influx resurges [46] . Thus, resurgent currents generate a depolarizing drive during membrane repolarization that may enable the generation of another action potential [47] . In this manner, resurgent currents contribute to increased neuronal activity.
Two types of resurgent currents have been identified in DRG neurons based on their kinetics: fast and slow. Under normal conditions, Nav1.6 predominantly mediates fast resurgent currents [6] , whereas Nav1.8 mainly mediates slow resurgent currents [55] . In this study, we investigate how fast resurgent currents are modulated in DRG neurons. There is a breadth of evidence that implicates fast resurgent currents in increased neuronal activity and pain pathologies such as radicular pain [71] , oxaliplatin acute painful neuropathy [53] , ATX-II induced pain [29] , and paroxysmal extreme pain disorder [28, 56] . Interestingly, recent studies using animal models of inflammatory, neuropathic, and chemotherapeutic induced pain suggest that Nav1.6 has an important role in mediating painful sensations [9, 38, 52, 53, 68, 70] . Together, these findings suggest targeting Nav1.6-mediated activity, such as resurgent currents, may provide novel strategies for pain therapeutics. However, our understanding of how fast resurgent currents are modulated in DRG neurons is fairly limited. Sodium channel auxiliary subunits are potential candidates for resurgent current modulation. For example, we recently reported that sodium channel beta 4 subunit (Navβ4) is a major determinant of resurgent currents in DRG neurons [3] . Our results were consistent with central nervous system (CNS) studies, which proposed the Cterminal sequence of this subunit acts as an open-channel blocker [2, 21, 39] . In particular, a region of 20 amino acids within the cytoplasmic C-terminal region (known as the β4 peptide) is predicted to be a key for Navβ4 positive regulation of fast resurgent currents [57, 74] . Inclusion of the β4 peptide in cell lines and neurons that do not endogenously generate resurgent currents evokes them [42, 51] . Similar effects are observed in DRG neurons, where inclusion of the β4 peptide or expression of the full-length Navβ4 protein evokes and enhances resurgent currents [64] . In contrast, overexpression of a mutant form of Navβ4 in which key residues within the β4 peptide region were neutralized reduced resurgent current generation, further confirming the importance of this region for resurgent current generation.
Fibroblast growth factor homologous factors (FHF1-4 also known as FGF11-14) are another family of auxiliary proteins that recent studies suggest regulate resurgent currents in CNS neurons [57, 74] . Contrary to their homolog counterpart, FHFs are not secreted and function independent of fibroblast growth factor receptors [42, 51] . Thus, FHFs are intracellular signaling proteins that have multiple interacting partners including microtubules [64] , kinases [62] , scaffolding proteins [50, 51] , nuclear factors [30] , calcium channels [73] , and VGSCs [19, 76] . FHF interaction with VGSCs can alter the biophysical properties of activation, inactivation and current density [19, 43] . Adult DRG neurons can express a variety of FHF isoforms including FHF1, FHF2, and FHF4 [27, 35, 48, 63, 76] . Each FHF gene can result in different isoforms through alternative splicing and promoter usage resulting in distinct N-terminal sequences [40] . Both BA^and BB1 isoforms have conserved core domains that enable them to bind to the C-terminus of sodium channels [18, 36, 58, 60] .
FHF BA^isoforms have two distinct features: (1) a long Nterminal sequence and (2) a bipartite nuclear localization signal (NLS), which may be active or inactive depending on the cell background [54] . FHFAs unique N-terminus expresses a peptide sequence (which is highly conserved between all FHFAs) that may interact with VGSCs and induce long-term inactivation [16] . This long-term inactivation particle competes with the intrinsic mechanism of inactivation (fast inactivation). Open-channel block, which mediates resurgent currents, also competes with fast inactivation [34] . Based on these observations, Goldfarb et al. (2012) proposed that long-term inactivation might compete with open-channel block [20] . In a Nav1.5 cell line, addition of long-term inactivation peptide reduced β4-peptide-mediated resurgent currents, supporting the possibility that these particles compete with each other [57] . In contrast, FHF BB^isoforms do not mediate long-term inactivation but may alter voltage dependence and kinetics of inactivation in ways that likely favor open-channel block [19] . For example, FHF4B in Purkinje neurons increased resurgent currents by slowing the rate of inactivation and shifting the voltage dependence of inactivation to positive potentials increasing the probability of binding for the endogenous open-channel blocker [74] . It is important to note that not all FHF isoforms are reported to have the same effect with all VGSC isoforms. For Nav1.6, heterologous coexpression of FHF2 and FHF4 isoforms consistently caused a shift in the voltage dependence of inactivation to positive potentials, whereas differential effects were observed in current density depending on VGSC isoform and cell background. In ND7/23 cells, FHF2 isoforms exhibited differential effects in response to trains of stimulation. FHF2A caused accumulation of inactivation at all frequencies due to slowing recovery from inactivation, whereas FHF2B protected the channel from inactivation at high frequencies with no change in recovery [48, 63] . In this study, we investigate the role of FHF2 isoforms (also known as FGF13) in regulating fast resurgent currents because they have been shown to colocalize with Nav1.6 (the main carrier of fast resurgent current) in DRG neurons. Therefore, we hypothesized that FHF2A inhibits fast resurgent currents in sensory neurons through long-term inactivation. In contrast, FHF2B lacks the ability to mediate long-term inactivation and may alter inactivation favoring open-channel block. Therefore, we hypothesized that FHF2B increase resurgent currents by delaying inactivation.
Our results show that FHF2A negatively regulates resurgent currents and enhances long-term inactivation, whereas FHF2B positively regulates resurgent currents and does not alter long-term inactivation. Data obtained from chimeric constructs of FHF2A and Navβ4 provided insight into the importance of FHF2A's long-term inactivation particle and the Navβ4 open-channel blocker sequence for the direction (positive versus negative) of resurgent current modulation. In neurons harvested from animals with localized inflammation of the DRG, we observed reduced FHFAs' expression whereas FHF2B's expression was enhanced. Our findings suggest that this differential modulation of FHF2A and FHF2B could contribute to enhanced resurgent currents and result in sensory neuron hyperexcitability. Interestingly, neuron hyperexcitability associated with localized inflammation of the DRG was substantially reduced by FHFA peptides that induce long-term inactivation. Overall, our data indicate that FHFs are important regulators of VGSC activity in sensory neurons and suggest that alterations in FHF2A and FHF2B expression likely contribute to changes in nociception and pain.
Methods cDNA constructs
These studies used cDNA constructs of sodium channel auxiliary subunits, FHF2A, FHF2B and chimeric constructs of FHF2A and Navβ4. All constructs were tagged at the Cterminus with photostable monomeric Turquoise2 (pmTurquoise2) to verify expression. To generate the FHF2A and FHF2B tagged constructs, the coding sequence corresponding to mouse FHF2A (NP_034330.2) and human FHF2B (NP_378668.1) were synthesized and purchased from Genscript (Piscataway, NJ). Mouse FHF2A protein is 99.56% identical to human FHF2A (NP_004105.1) and is predicted to be 100% identical to rat FHF2A (NC_005120.4). Human F H F 2 B p r o t e i n i s 9 9 . 4 8 % i d e n t i c a l t o m o u s e (NP_001277344.1) and rat FHF2B (NP_445880.1). The FHF2A sequence was cut from a pUC57 vector and inserted into pmTurquoise2-N1 vector with HindIII/KpnI restriction enzymes. The FHF2B sequence was cut from pcDNA3.1 (+) vector and inserted into pmTurquoise2-N1 vector with HindIII/BamHI restriction enzymes. The sequences were moved in-frame by site-directed mutagenesis (Quikchange XL II Site Directed Mutagenesis kit, Agilent Technologies).
The chimeric constructs of FHF2A and Navβ4 were designed in-house by replacing the long-term inactivation particle sequence (AAAIASSLIRQKRQAREREK, 20 amino acids (16) ) with the Navβ4 open-channel blocker sequence (KKLITFILKKTREKKKECLV, 20 amino acids [33] ) to generate the F2A(β4) construct. Conversely, the open-channel sequence in rat Navβ4 (NP_001008880.1) was replaced with the long-term inactivation particle of FHF2A to generate the β4(F2A) construct. The full chimeric sequences were synthetically made and purchased from Genscript (Piscataway, NJ). The F2A(β4) and β4(F2A) sequences were cut from the pUC57 vector and subcloned into pmTurquoise-N1 with NheI/XhoI restriction enzymes. To move the sequences in-frame with the fluorescent protein, the stop codon was mutated to a glycine residue using site-directed mutagenesis.
To study Nav1.6 in isolation from endogenous TTXS channels, we used a Nav1.6 TTXR construct previously described in [44] . Briefly, the sequence corresponding to human Nav1.6 protein (NP_055006.1) was codon-optimized and purchased from Genscript (Piscataway, NJ). The sequence was then subcloned into pcDNA3.1 (+) with KpnI/XbaI restriction enzymes. The Nav1.6 sequence was then modified with site directed mutagenesis to confer high resistance to TTX by converting tyrosine residue 371 to serine as previously described [24, 32] . The resulting construct was named Nav1.6r. Additionally, we knocked down endogenous TTXR Nav1.8 channels with a small hairpin RNA (shRNA) plasmid to aid in the isolation of Nav1.6r currents. The Nav1.8 shRNA-IRES-dsRED plasmid encoded for Nav1.8 shRNA sequence (targeting sequence, GATGAGGTCGCTGC TAAG, [37] and an internal ribosome entry site for the translation of fluorescent protein marker dsRed (IRES-dsRED) as previously described [3, 28] .
Cell culture
DRG neurons were obtained from adult male SpragueDawley rats. Rats were euthanized by CO 2 exposure and secondary decapitation. The spinal column was then removed, and DRG were harvested from the lumbar to cervical region. The nerve processes were cut from the excised ganglia. Ganglia were then digested in Dulbecco' modified Eagle's medium (DMEM, Fisher Scientific) containing collagenase (1.25 mg/mL) and neutral protease (0.78 mg/mL) for 45 min at 37°C. Subsequently, the digested ganglia were centrifuged at 1000 rpm for 5 min. Digestion media was aspirated and replaced with 10% fetal bovine serum (FBS, Hyclone) DMEM (Invitrogen), and ganglia were mechanically triturated with sequentially smaller glass pipettes. Triturated ganglia were spun again at 700 rpm for 5 min. Media was aspirated and replaced with fresh 10% FBS DMEM media. Aliquots of cell suspension (∼100 μL) were loaded unto glass coverslips coated with poly-D-lysine and laminin. After 10 min, cells settled and 500 μL of 10% FBS DMEM was added to each well. For electrophysiological experiments with transfected neurons, the 10% FBS DMEM media was supplemented with mitotic inhibitors, 5-fluoro-2-deoxyuridine (50 μM, Sigma Aldrich) and uridine (150 μM, Sigma Aldrich), to prevent overgrowth of the supporting cells. Dissociated cultures were maintained at 37°C in a humidified 95% air and 5% CO 2 incubator. Media was changed every 2 days.
For localized inflammation of the DRG (LID) experiments, L4 and L5 ipsilateral DRG were excised from sham-operated rats and inflammation-induced rats at postoperative day 5. The above dissociation protocol and culture was followed with the exception of the digestion time, which was decreased to 28 min. Indiana University School of Medicine Institutional Animal Care and Use Committee approved the animal protocols described above.
Surgical procedure for localized inflammation of the DRG Localized inflammation of the DRG was used as a model of radicular pain as previously discussed in [75] and described in [66] . Adult male Sprague-Dawley rats under isoflurane anesthesia were used for these procedures. After deep anesthesia was verified, an initial incision on the back near the spinal column was made from L3-S1 to expose and visualize the superficial area of the spine. Then, a second deeper incision was made on one side of the animal approximately 1 mm from the center of the spine from L4 to S1. Paraspinal muscles near L4/L5 were carefully teased apart until intervertebral foramen could be visualized using the transverse processes, ilium and dorsal/ventral ramus as guides. Aliquots of 10 μL containing zymosan diluted in incomplete Freud adjuvant (2 mg/mL) were injected above L4 and L5 DRG, through a needle inserted close to the DRG through the intervertebral foramen. The needle was bent in a 90°angle ∼2 mm from the tip for easier access and was left for 2 min after injection to prevent leakage. After injection, the area was sutured by layers. Shamoperated animals were used as a control; the above procedure was followed with the exception of zymosan injection. Indiana University School of Medicine and University of Cincinnati Institutional Animal Care and Use Committees approved the surgical procedure described.
Behavioral measurements
Mechanical sensitivity was tested by applying a series of von Frey filaments to the heel region of the paws on animals with L5 localized inflammation, using the up-and-down method [5] . A cutoff value of 15 g was assigned to animals that did not respond to the highest filament strength used. A fine wisp of cotton was stroked mediolaterally across the plantar surface of the hindpaws to score the presence or absence of a brisk withdrawal response to a normally innocuous mechanical stimulus (light touch-evoked tactile allodynia). This stimulus does not evoke a response in normal animals. Cold sensitivity (cold allodynia) was scored as withdrawal responses to a drop of acetone applied to the ventral surface of the hind paw. When observed, responses to acetone or light brush strokes consisted of several rapid flicks of the paw and/or licking and shaking of the paw; walking movements were not scored as positive responses. Hypersensitivity to thermal (heat) stimuli was not examined because we have previously observed that this is little affected by LID [72] . The tester was blinded as to the sham or LID status of the animals. All data presented are from the ipsilateral side; in this model, the contralateral side shows little or no hypersensitivity in any of the tests used (data not shown). Behavioral time course data were analyzed using two-way repeated measures ANOVA with Bonferroni post hoc test to determine on which days experimental groups differed. The experimental protocol was approved by the Institutional Animal Care and Use Committee of the University of Cincinnati.
Immunocytochemistry
To study the expression pattern of FHF2A and FHF2B after inflammation, L4 and L5 ipsilateral DRG ganglia were harvested and cultured from sham operated and inflammation induced animals at postoperative day 5. DRG neurons were fixed after 24 h in culture, permeabilized, blocked, and treated with antibodies in the following manner: cells were fixed with 4% paraformaldehyde (0.1 M phosphate buffer, pH 7.4) for 20 min at room temperature, washed with phosphate-buffered saline (PBS), permeabilized in 1% Triton X-100 in PBS for 20 min at room temperature, washed with PBS, blocked for 2 h (10% normal goat serum, 0.1% Triton X-100 in PBS) at room temperature, washed with PBS, incubated in primary antibodies diluted in blocking solution overnight at 4°C, washed with PBS and incubated with secondary antibody in blocking solution for 2 h at room temperature. Primary antibodies used were Anti-Pan-FHF-A (1:200, Clone N235/22, UC Davis/NIH NeuroMab Facility) and monoclonal Anti-FGF13/FHF2.B (1:200, Clone N225A/10, UC Davis/NIH NeuroMab Facility). Secondary antibody used was Alexa Fluor® 488 Goat Anti-Mouse IgG (Molecular Probes, Life Technologies) at 1:750 concentration. Coverslips were mounted unto microscope slides with Prolong Gold Antifade (Molecular Probes). DRG neurons were imaged using Axio Observer Z1 Widefield Microscope with a ×20 objective (ZEISS Microscopy). Images were analyzed using NIS Elements Advance Research (Nikon®) software by defining each cell as a region of interest and quantifying the mean intensity signal for FHF2A and FHF2B. The mean intensity signal was compared between sham and LID groups using Student's t test. Quantification experiments were carried out independently at least five times; more than 1000 cells were counted for each condition.
Recombinant expression in DRG neurons
DRG neurons were transiently cotransfected with Nav1.6r, tagged auxiliary subunit and Nav1.8 shRNA-IRES-dsRED using the Helios Gene Gun (Bio-Rad Laboratories) 36-48 h after dissociation in 2:1:1 ratio, respectively. As a negative control, pmTurquoise 2 (tag only) was cotransfected instead of the auxiliary subunits. For peptide studies, only Nav1.6r and Nav1.8 shRNA-IRES-dsRED were cotransfected. Expression of the Nav1.6r construct with Nav1.8 shRNA allowed us to study the modulation of Nav1.6r by auxiliary subunits in isolation from endogenous channels as previously described [3, 28] . Although endogenous TTXR Nav1.8 channels run down in culture [17, 28] , by using the Nav1.8 shRNA-IRES-dsRED plasmid, we further decreased Nav1.8 to minimize contamination. TTXR Nav1.9 currents are not observed under our recoding parameters as previously reported [7, 11] . Endogenous TTXS channels were blocked with 500 nM.
Electrophysiology and data analysis
General setup Whole-cell patch-clamp recordings obtained with a HEKA EPC-10USB amplifier. Data were acquired on a Windows-based Intel 2 Core computer using the Patchmaster program (version 2X65; HEKA Elektronik). Fire polished glass electrodes (0.7-1.1 MΩ) were fabricated using a P-97 puller (Sutter), and tips were coated with dental wax to minimize capacitive artifacts and enhance series resistance compensation. The offset potential was zeroed prior to seal formation. Capacitive transients were canceled using computercontrolled circuitry: C-fast for pipette-capacitance correction and C-slow for cell-capacitance compensation. Voltage errors were minimized by series resistance compensation >75%. Membrane currents were sampled at 20 kHz and filtered online at 10 kHz. Leak currents were linearly canceled by P/-5 subtraction (pulse/number). Whole-cell patch-clamp recordings in voltage clamp mode were obtained 2-3.5 days after transfection at room temperature (∼22°C). Cells examined were selected based on fluorescence of Turquoise (corresponding to auxiliary subunit) and dsRed (corresponding to Nav1.8 shRNA) signal. For peptide studies, the dsRed signal only was used as selection criteria since no auxiliary subunits were cotransfected. Cells with residual Nav1.8 current greater than 3% of the peak current of Nav1.6r were excluded. Nav1.8 contamination was determined by examining the voltage dependence of steady-state fast inactivation as described previously [3] . Whole-cell voltage clamp recordings were started 5 min after the whole-cell configuration was obtained.
For current-clamp recordings, DRG neurons were allowed to settle at their resting potential. Spontaneous activity was defined as firing observed during 2 min with zero current injection. DRG neurons were examined for evoked activity with a series of 2-s current injection from 100 to 500 pA in 100-pA increments. For evoked activity, the maximum number of action potentials elicited from each cell was determined as the maximum action potentials elicited from current injections from 0 to 500 pA. Electrophysiology data were analyzed using the software programs Origin (version 8, OriginLab), Fitmaster (v2X65, HEKA Electronik), and Excel (Microsoft), and final graphs were made in Prism (version 6, GraphPad).
Recording solutions
The electrode solution consisted of 140 mM CsF, 10 mM NaCl, 1.1 mM EGTA, and 10 mM HEPES (adjusted to pH 7.3 with CsOH). The extracellular bathing solution contained 130 mM NaCl, 30 mM TEA chloride, 1 mM MgCl2, 3 mM KCl, 1 mM CaCl 2 , 0.05 mM CdCl2, 10 mM HEPES, and 10 mM D-glucose (adjusted pH 7.3 with NaOH). For current-clamp recordings, the pipette solution contained 140 mM KCl, 0.5 mM EGTA, 5 mM HEPES and 3 mM Mg-ATP (adjusted pH 7.3 with KOH). The extracellular solution contained 140 mM NaCl, 3 mM KCl, 2 mM MgCl2, 2 mM CaCl 2 , and 10 mM HEPES (adjusted pH 7.3 with NaOH). Recording solutions were adjusted using D-glucose to maintain physiological osmolarity values.
Peptide experiments To study the effects of FHF2A's longterm inactivation particle, we used a peptide corresponding to amino acids residues 2-21 as reported in [16] . The peptide, FHFA, was modified with an N-terminal acetyl group and Cterminal hydroxyl group yielding the following sequence: Ac-AAAIASSLIRQKRQAREREK-OH (purchased from Biopeptides Co). The FHFA peptide was added to the electrode solution at a 1 mM concentration. Control groups included either having no peptide added to the intracellular solution or adding an inactive mutant FHFA-5Q peptide (Ac-AAAIASSLIRQQQQAQEQEQ-OH from Biopeptides Co) to the electrode solution at a 1 mM concentration.
Steady-state activation Current-voltage (I/V) relationships were determined by steps of 50 ms, from −100 to +80 mV, in 5-mV increments. The voltage dependence of activation (m ∞ ) was determined from sodium currents elicited with I/V protocol from voltages of −100 to 0 mV. Conductance (G) values were calculated at each test potential (V m ) using the reversal potential (V r ) with the following equation:
Þ . Data was then normalized to the peak conductance, plotted as a function of voltage and fitted using singlephase Boltzmann distribution equation,
The midpoint points (V 1/2 ) and slope factor (k) were obtained for each cell.
Steady-state inactivation Steady-state fast inactivation (h ∞ ) was assayed with 500 ms pre-pulses from −130 to 5 mV (in 5-mV increments) followed by a 20-ms test pulse to −20 mV to assess channel availability. Current peak currents at each prepulse were normalized to the overall peak current. Data of normalized currents as a function of voltage was fitted with the single phase Boltzmann distribution
from which the midpoint points (V 1/2 ) of steady-state fast inactivation and slope factor (k) were obtained for each cell. Additionally, current densities were estimated for each individual recording by dividing the peak transient currents obtained from h ∞ by the membrane capacitance.
Recovery from inactivation Recovery from inactivation was assayed with a two-pulse protocol that depolarized the membrane to −20 mV for 20 ms from holding potential (−100 mV). The time between the pulses was increased by an additive 2 n factor, where n = sweep number. At each time point, the peak current measured in the second pulse (I 2 ) was normalized to the peak current measured in the first pulse (I 1 ), yielding fraction available. Fraction available (
Þ was plotted as a function of time (t) and fitted to a double exponential equation,
, from which we obtained the recovery time constants for the fast (τfast) and slow component (τslow) and compared between groups.
Accumulation of long-term inactivation Cells were assayed with a four-pulse protocol, as previously described [16] , to measure long-term inactivation. Each pulse depolarized the membrane to −20 mV for 16 ms from a holding potential of −90 mV with −90 mV 40-ms interpulse recovery phases between each depolarization pulse. Peak current measured at each pulse was normalized to overall peak current to yield percentage of sodium channels available. The % of channels available was plotted as a function of depolarization cycle (i.e., pulse number).
Resurgent current Cells were assayed with a two-pulse protocol that initially depolarized the membrane to +30 mV for 20 ms from the holding potential (−100 mV), followed by repolarizing voltage steps from +15 mV to −80 for 100 ms in −5 mV increments to test for resurgent currents; cells were then returned to their holding potential (−100 mV). Resurgent currents display unique characteristics of slow onset and slow decay along with a nonmonotonic I/V relationship. Currents that did not meet these criteria were classified as negative for resurgent currents. Based on these criteria, the percentage of DRG that were positive/negative for detectable resurgent current was quantified for each condition. Resurgent current amplitudes were measured after 3.0 ms into the repolarizing pulse to avoid contamination from tail currents. Peak resurgent current amplitude at each test potential was normalized to peak transient current (obtained from the h ∞ protocol) and expressed as a percentage of peak transient current.
Normalized resurgent current amplitude was plotted as a function of voltage.
Statistics
Data are presented as mean ± standard error of the mean (SEM). The data were tested for Gaussian distribution fit with D'Agostino and Pearson omnibus normality test. Data that fit Gaussian distribution were compared with parametric test, Student's t test at a 95% level of confidence (α = 0.05). Data that did not fit Gaussian distribution were compared with a non-parametric Mann-Whitney test with 95% level of confidence (α = 0.05). The chi-squared test (χ 2 test) was used to compare the frequency distribution of resurgent current positive/negative neurons and repetitive action potential firing between groups at a 95% level of confidence (α = 0.05).
Results
Biophysical properties of Nav1.6r with FHF2A and FHF2B
We first examined if in DRG neurons FHF2A could mediate the characteristic long-term inactivation that has been reported in other cells with FHFAs variants [16, 48] . Primary cultured DRG neurons were biolistically cotransfected with Nav1.6r and tagged-FHF2A or tagged-FHF2B. As a negative control, tag only (pmTurquoise2; fluorescent protein) was transfected instead of a FHF subunit. Whole-cell voltage-clamp recordings of isolated Nav1.6r were obtained by pharmacological (addition of 500 nM TTX) and genetic (Nav1.8shRNA; see BMethods^) inhibition of endogenous DRG sodium currents. Long-term inactivation was measured using a four-pulse protocol consisting of depolarizations to -20 mV for 16 ms with 40-ms interpulses at −90 mVas described by Dover et al. [16] . Representative traces obtained with this long-term inactivation assay are shown in Fig. 1a for each group. Overexpression of FHF2A increased accumulation of Nav1.6r in long-term inactivated states, consistent with previous reports [16, 48] . FHF2A progressively decreased Nav1.6r availability with each depolarization cycle relative to control (Fig. 1b , minimum sodium channel availability p p < 0.0001: FHF2A 72 ± 3%, n = 18; control 90 ± 2%, n = 28), whereas FHF2B did not (p = 0.62, FHF2B 91 ± 2%, n = 13).
We also examined how FHF2A and FHF2B alter other biophysical properties of Nav1.6r in DRG neurons since in different cell backgrounds FHFs' interaction with VGSCs have been reported to alter current density, inactivation, activation, and recovery as previously discussed [43] . I/V relationship was determined with a single-pulse protocol that ranged from −100 to 80 mV for 50 ms. Using the I/V protocol, we quantified peak current density and activat ion. Overexpression of FHF2A or FHF2B did not alter peak current density of Nav1.6r relative to control (Table 1 , p = 0.32 and p = 0.37, respectively). FHF2A did shift the voltage dependence of activation to more positive potentials (Fig. 1c , p = 0.0063), whereas FHF2B did not, relative to control (Table 1 , p = 0.50). Steady-state inactivation was assayed by conditioning the cells with a pre-pulse that ranged from −130 to 5 mV for 500 ms followed by a test pulse to −20 mV for 20 ms. Consistent with previous reports [48, 59, 60, 63] , FHF2A and FHF2B shifted the voltage dependence of inactivation to more depolarized potentials (Fig. 1d , p = 0.0013 and p = 0.026, respectively). Recovery from inactivation was assayed with a two-pulse step protocol that depolarized the membrane to −20 mV for 20 ms with increasing time between pulses (recovery phases). Figure 1e shows that FHF2A slowed recovery from inactivation (Table 1 ; τfast, p = 0.16, and τslow, p = 0.012), whereas FHF2B enhanced recovery from inactivation relative to control (Table 1 ; τfast, p < 0.0001, τslow, p = 0.03). Table 1 shows a summary of recovery, inactivation, activation, and current density data.
Differential modulation of fast resurgent currents by FHF2A and FHF2B
We next investigated resurgent current modulation by these FHF2 isoforms. To do so, we used a two-pulse protocol that initially depolarized the cell membrane to 30 mV for 20 ms followed with a series of repolarization pulses from +15 to −80 mV for 100 ms. Resurgent current amplitudes were normalized to classic sodium peak current (maximum current obtained from the steady-state inactivation protocol) and expressed as percentage of peak current. Representative traces of resurgent currents are shown in Fig. 2a for each group. Overall, FHF2A reduced the fraction of resurgent current positive neurons (χ 2 test, p = 0.039), whereas FHF2B did not, relative to control (Fig. 2b , p = 0.60). FHF2A also reduced resurgent current amplitude relative to control ( Fig. 2c ; peak resurgent current amplitude p = 0.0021: FHF2A 0.371 ± 0.21%, n = 18; control 1.14 ± 0.27%, n = 29). FHF2B exhibited the opposite effect, doubling peak resurgent current amplitude relative to control (p = 0.0034: FHF2B 2.41 ± 0.22%, n = 13).
FHFA peptide replicates long-term inactivation effects and reduced Nav1.6r-mediated resurgent currents FHF2A has two known potential interactions that might contribute to Nav1.6r modulation: (1) binding to the C-terminal of sodium channels and (2) long-term inactivation particle binding (presumably to the inner pore region). We hypothesized that FHF2A's long-term inactivation particle is the main contributor for the observed negative regulation of fast resurgent currents. To explore this possibility, we used a peptide (FHFA peptide) corresponding to amino acid residues 2-21 in FHF2A protein, previously identified as the long-term inactivation particle [16] . FHFA peptide (1 mM) was added to the internal recording solution as described by Dover et al. DRG neurons were transfected with Nav1.6r, and recombinant currents were isolated as described in the BMethods^section. Voltage-clamp recordings were obtained 5 min after dialysis of the internal solution in the presence or absence of the peptide. Using the protocols previously described, we examined current density, activation, inactivation, recovery, long-term inactivation, and resurgent currents. Representative traces of Fig. 1 Biophysical properties of Nav1.6r modulated by FHF2A and FHF2B. DRG neurons were transfected with Nav1.6r and FHF2A, FHF2B or fluorescent protein tag (control). a Representative traces of cycle-dependent reduction as a measure of accumulation of long-term inactivation (LTI) for control (black), FHF2A (blue), and FHF2B (purple) groups. b The percentage of channels available as a function of depolarization cycle shows overexpression of FHF2A (n = 19) increased accumulation of long-term relative to control (n = 28), whereas FHF2B (n = 13) did not. Activation, inactivation, and recovery from inactivation were assayed with a series of standard protocols (see BMethods^sec-tions). c Normalized conductance (G/Gmax) as a function of voltage shows that FHF2A (blue squares, n = 16) overexpression shifted the voltage dependence of activation relative to control (black circles, n = 25). No change is observed for FHF2B overexpression (purple diamonds, n = 11) relative to control. d Normalized current (I/Imax) as a function of voltage shows that voltage dependence of inactivation was shifted to positive potentials in FHF2A (n = 19) and FHF2B (n = 13) groups relative to control (n = 27). e Fraction of channels available as a function of time shows FHF2A (n = 19) overexpression greatly slowed recovery from inactivation relative to control (n = 15), whereas FHF2B (inset, n = 12) enhanced channel recovery. LTI long-term inactivation; Asterisks represent p < 0.0001 obtained from Student's t test. Data are mean ± SEM (color figure online) Groups were compared to control using Student's t test (parametric) or Mann-Whitney U test (nonparametric). Data are mean ± SEM τ time constant, k slope factor of activation or inactivation curve, V 1/2 midpoint of activation or inactivation curve *p < 0.05 (vs control); **p < 0.0001 (vs control)
long-term inactivation test are shown in Fig. 3a, b . Dialysis of the FHFA peptide greatly increased accumulation of Nav1.6r in long-term inactivated states (Fig. 3c , minimum sodium channel availability p < 0.0001: +FHFA 29 ± 3%, n = 15; −FHFA 84 ± 2%, n = 16). Recovery from inactivation was significantly slowed in the +FHFA peptide group relative to the −FHFA peptide group (Fig. 3d and Table 2 ; τfast, p = 0.034, and τslow, p = 0.012). Addition of the FHFA peptide did not alter Nav1.6r current density (p = 0.054), voltage dependence of activation (p = 0.21), or inactivation relative to control (p = 0.95). Table 2 shows a summary of current density, activation, and inactivation data. We next examined resurgent currents with a two-step protocol as previously described. Representative traces of peak Nav1.6r resurgent currents are shown in Fig. 3e . The +FHFA peptide group exhibited reduced resurgent current amplitudes relative to −FHFA peptide group (Fig. 3f , peak resurgent current p < 0.0001: +FHFA peptide 0.3 ± 0.2, n = 15; −FHFA peptide 1.5 ± 0.4%, n = 16). The fraction of resurgent current positive neurons was also greatly reduced in the +FHFA peptide group (chi-squared test p = 0.0032: 20%, n = 15) relative to control −FHFA peptide (69%, n = 16). An additional set of experiments was performed to determine if these effects were specific to the FHFA peptide or could be induced by any peptide. Dover et al. showed that substitution of five charged residues in the N-terminus of FHF2A with glutamines eliminates the ability of FHF2A to induce long-term inactivation [16] . We synthesized the corresponding FHFA-5Q peptide and added it at 1 mM to the internal recording solution. When neurons recorded with FHFA-5Q peptide (n = 14) were compared to neurons recorded with no added peptide (n = 7), there was no difference in terms of accumulation in long-term inactivated states (p = 0.66), kinetics of recovery from inactivation (p = 0.90), and resurgent current amplitude (p = 0.74), indicating that FHFA peptide effect is dependent on the specific amino acid sequence.
Modulation of Nav1.6r by chimeric constructs of Navβ4 and FHF2A
The FHF2A long-term inactivation particle is potentially inhibiting fast resurgent currents by out-competing the openchannel blocker Navβ4 [3] . Therefore, we investigated if replacing the proposed open-channel blocker sequence in Navβ4 with FHF2A's long-term inactivation sequence would transfer the long-term inactivation activity and reduce resurgent currents in DRG neurons. Conversely, we replaced the long-term inactivation sequence in FHF2A with the open channel blocker in the Navβ4 protein and hypothesized that this construct would increase resurgent current. The sequences were codon-optimized and synthetically made (see BMethods^section). The resulting chimeric constructs were named F2A(β4) for the FHF2A protein containing the Navβ4 open-channel sequence and β4(F2A) for the Navβ4 protein containing the FHF2A long-term inactivation sequence (Fig. 4) . Both constructs were tagged at the C-terminus with a fluorescent protein, pmTurquoise2, to verify expression. DRG neurons were biolistically transfected with Nav1.6r and a chimeric construct. As a control, tag only was expressed instead of a chimeric subunit. Nav1.6r currents were isolated following inhibition of endogenous sodium currents as previously described. Using the recording protocols previously described, we examined the biophysical properties of Nav1.6r with coexpression of β4(F2A) or F2A(β4) and investigated if the chimeric constructs modulated resurgent currents. Representative traces from a long-term inactivation protocol test for each group are shown in Fig. 5a . β4(F2A) slightly increased accumulation of long-term inactivation relative to control (Fig. 5b : minimum sodium channel availability p = 0.034: β4(F2A) 84 ± 2%, n = 12; control 89 ± 2%, n = 14), whereas F2A(β4) did not alter accumulation of long-term inactivation (88 ± 2%, n = 9). Expression of either chimera, β4(F2A) or F2A(β4) did not alter current density relative to control (Table 3 , p = 0.82 and p = 0.35, respectively). In a similar pattern as seen with FHF2A, F2A(β4) expression shifted the voltage dependence of activa?>tion (Fig. 5c , p = 0.047) and inactivation (Fig. 5d , p = 0.0089) of Nav1.6r to positive potentials relative to control, whereas β4(F2A) did not alter either (Table 3 , p = 0.36 and p = 0.29, respectively). Expression of F2A(β4) enhanced Nav1.6r recovery from steady-state inactivation relative to control ( Fig. 5e, inset ; τfast, p = 0.0010, and τslow, p = 0.36). Groups were compared using Mann-Whitney t test or Student's t test. Data are mean ± SEM τ time constant, k slope factor of activation or inactivation curve, V 1/2 midpoint of activation or inactivation curve *p < 0.05; **p < 0.0001 β4(F2A) did not slow or enhance Nav1.6r recovery from inactivation relative to control ( Fig. 5e and Table 3 ; τfast, p = 0.50, and τslow, p = 0.36).
Differential modulation of fast resurgent currents by F2A(β4) and β4(F2A) chimeras
We next examined Nav1.6r-mediated resurgent currents with a two-step protocol (BMethods^section). Resurgent current amplitude was expressed as percentage of peak current. Representative traces of resurgent currents for each condition are shown in Fig. 6a . Figure 6b shows the distribution of resurgent current positive and resurgent current negative neurons for each condition. Overall, the percentage of resurgent current positive neurons was not significantly different with expression of β4(F2A) or F2A(β4) relative to control (p = 0.30 and p = 0.52, respectively). The percentage of resurgent current positive neurons was 33% for β4(F2A), 67% for F2A(β4) and 53% for control. However, F2A(β4) expression increased resurgent current amplitude by threefold factor relative to control (Fig. 6c peak resurgent current p = 0.0023: F2A(β4) 3.1 ± 0.8%, n = 9; control 1.2 ± 0.4%, n = 15). In contrast, β4(F2A) exhibited the opposite effect reducing resurgent current amplitude by two-fold factor (β4(F2A) p = 0.0076: 0.4 ± 0.2%, n = 12).
FHFa in a radicular inflammatory pain model
The results of overexpression of FHF2A and FHF2B, FHFA peptide and chimeric constructs suggest that FHF2A and FHF2B isoforms regulate resurgent currents and may contribute to pain pathologies. We previously reported that resurgent currents are increased in a rat model of radicular pain [71] . In this model, localized inflammation of the DRG (LID) causes persistent mechanical hyperalgesia and allodynia that starts as soon as postoperative day 1 [67] [68] [69] 71] . Therefore, we chose to examine FHF2A and FHF2B expression and the effect of FHFA peptide on neuronal excitability using acutely cultured neurons harvested from rats on day 5 following LID. To examine FHF2A and FHF2B expression, Sprague-Dawley rats were injected with zymosan at a 2 mg/mL concentration above the L4 and L5 DRG on one side (see BMethods^). Sham-operated rats that underwent the same procedure with the exception of the injections were used as a control. In order to confirm that the LID but not the sham procedure used evoked pain behaviors on the day the animals were sacrificed for obtaining cultured DRG neurons, behavioral measures of mechanical and cold hypersensitivity were measured at baseline and for 5 days after DRG inflammation or sham surgery. As shown in Supplementary Fig. S1 , static and dynamic mechanical allodynia and cold allodynia were significantly elevated in LID animals compared to sham animals, starting as early as POD1 and continuing through POD5. At postoperative day 5, L4/L5 ipsilateral DRG were harvested from LID and sham-operated animals. FHFA and FHF2B levels were examined in primary DRG cultures with immunocytochemistry. One caveat with the FHFA antibody used is that it is not selective to the FHF2A isoform, but rather the antibody used targets the long-term inactivation particle which is highly conserved between all FHFAs. However, in adult DRG neurons, FHF4A is not expressed and FHF1A is downregulated in adulthood [27] . FHF1A contains a nuclear localization signal that is functional in DRG neurons and targets the protein to the nucleus [27] . In contrast, FHF2A nuclear localization signal is predicted to be inactive since staining is limited to the cell periphery and not detected in the nucleus in adult DRG neurons [48] . Therefore, given that our model is an adult DRG neuron, we expect that cross-reaction is minimal and likely most of the antibody signal is reflecting FHF2A expression. Representative images of FHFA staining in Fig. 4 Chimeric constructs of FHF2A and Navβ4. a Illustration of FHF2A and Navβ4 subunits. The Navβ4 subunit consists of an extracellular N-terminal domain, a single transmembrane domain and a cytosolic C-terminal domain. The cytosolic domain contains a sequence of amino acids proposed to mediate open-channel block that generate resurgent currents (red sphere represents β4 peptide sequence, amino acids 183-203 [2, 33] ). The FHF2A subunit is a cytosolic protein, which contains a core region homologous to all FHF with a C-terminal epitope that enables interaction with the cytoplasmic C-terminal region of sodium channels [18] . Distinct from its FHF2B counterpart, the FHF2A Nterminus sequence is much longer and contains a sequence identified as the long-term inactivation particle (blue sphere, amino acids 1-20 (16)). Arrow between the subunit highlights the region that was exchanged between these subunits to generate the chimeric constructs. b Illustration of the resulting chimeric constructs. The (β4)F2A contains all components of the Navβ4 subunit with the exception of β4 peptide sequence, which was replaced with long-term inactivation particle sequence. The F2A(β4) contains all domains of the FHF2A protein except the long-term inactivation particle, which was replaced with the β4 peptide sequence. Inset depicts the figure legend for the β4 peptide and longterm inactivation particle with the corresponding amino acid sequence (color figure online) Fig. 5 Biophysical properties of Nav1.6r modulated by β4(F2A) and F2A(β4) chimeras. Activation, inactivation, and recovery from inactivation were assayed with a series of standard protocols (see BMethods^sections). a Representative traces of cycle-dependent reduction as a measure of long-term inactivation (LTI) for Nav1.6r isolated currents in DRG neurons with coexpression of fluorescent tag (control, black), F2A(β4) (green), and β4(F2A) (orange). b The percentage of channels available as a function of depolarization cycle shows increased accumulation of long-term inactivation for β4(F2A) group (orange squares, n = 12) relative to control (black circles, n = 16), whereas no difference is observed for F2A(β4) group (green triangles, n = 8) relative to control. c Normalized conductance as a function of voltage shows that coexpression of F2A(β4 ) (n = 8) shifted the voltage dependence of activation to positive potentials relative to control (n = 14), whereas no change is observed for the β4(F2A) group (n = 12). d Normalized current as a function of voltage shows that coexpression of F2A(β4) (n = 9) shifted the voltage dependence of steady-state inactivation to positive potentials relative to control (n = 14), whereas no change is observed for the β4(F2A) group (n = 12). e Fraction of current available as a function of time shows that recovery is not significantly altered with coexpression of either chimera β4(F2A) (n = 12) or F2A(β4) (n = 9) relative to control (n = 14). Asterisks represent p < 0.05 obtained from Student's t test. Data are mean ± SEM (color figure online) Groups were compared to control using Student's t test (parametric) or Mann-Whitney U test (nonparametric). Data are mean ± SEM τ time constant, k slope factor of activation or inactivation curve, V 1/2 midpoint of activation or inactivation curve relative to sham control (Fig. 7f, FHF2B mean intensity p < 0.0001; LID 29.5 ± 1.6 AU, n = 1121; sham 21.04 ± 0.4 AU, n = 1164). Previously, we have shown that local inflammation of the L4/L5 DRG increases spontaneous activity of Aβ neurons and resurgent currents in cultured medium diameter neurons [71] . These effects are attenuated by Navβ4 knockdown. Here, we asked if LID-induced neuronal hyperexcitability could be affected by the FHFA peptide. For this set of experiments, we recorded action potential activity from medium diameter neurons harvested from sham and LID treated rats with either 1 mM FHFA peptide or 1 mM FHFA-5Q peptide in the intracellular pipette solution. Neurons from sham animals did not exhibit any spontaneous activity (Fig. 8a, b) with either FHFA-5Q peptide (n = 12) or FHFA peptide (n-10) in the pipette solution. By contrast, three of ten neurons from LID-treated animals exhibited spontaneous activity with FHFA-5Q peptide in the recording solution (Fig. 8c, d ). This is similar to what was observed previously with microelectrode recordings from Aβ fibers in an acutely isolated whole DRG preparation [68, 71] . By contrast, no spontaneous activity was observed in neurons when wild-type FHFA peptide was included in the internal recording solution (n = 14) and this difference was significant (p = 0.02846; chi-squared test). Evoked action potential firing was also examined with current injections in the four groups. In both sham and LID-treated neurons, the wild-type FHFA peptide substantially reduced the number of action potentials compared to the FHFA-5Q peptide (Fig. 8e-h ). Significantly more neurons generated multiple action potentials in response to current injections with FHFA-5Q in the pipette than with wild-type FHFA peptide in the pipette (p = 0.00104; chi-squared test).
Discussion
In this study, we show that FHF2A and FHF2B differentially regulate resurgent sodium currents in DRG sensory neurons. The first component of our hypothesis was that FHF2A limits the capacity of sensory neurons to generate fast resurgent currents by mediating long-term inactivation. Three main findings support this hypothesis. First, overexpression of FHF2A reduced resurgent current and increased accumulation of channels in inactivated states resulting in delayed channel No spontaneous activity (−SA) was detected on DRG neurons from sham rats when 1 mM FHFA (n = 10) or 1 mM 5Q (n = 12) was included in the pipette solution. c, d Thirty percent of DRG neurons from local inflammation of the DRG (LID) rats showed spontaneous activity (+SA) in the presence of 1 mM 5Q (n = 10), while no spontaneous activity was observed in the presence of 1 mM FHFA (n = 14). Representative action potential traces induced by a 2-s injection of 400-pA current on DRG neurons from sham (e) and LID (g) rats in the presence of 1 mM 5Q (left panel) or 1 mM FHFA (right panel). f, h Average number of action potentials induced by 2-s injection of currents ranging from 100 to 500 pA recovery. Secondly, a peptide derived from FHF2A's longterm inactivation particle recapitulated the reduction in resurgent current generation and the enhancement of long-term inactivation. The peptide did not modulate the voltage dependence of inactivation and activation as seen with full-length FHF2A, suggesting that these changes do not account for negative regulation of resurgent current. A mutant peptide (FHFA-5Q) was inactive. Thirdly, the F2A(β4) chimera (in which the long-term inactivation particle was replaced with Navβ4's open-channel blocker sequence) did not negatively regulate resurgent currents nor induced long-term inactivation. The chimera produced the opposite effect, an enhancement in resurgent current modulation, suggesting that the long-term inactivation particle region is a key for FHF2A's resurgent current modulation.
The second component of our hypothesis was that FHF2B increases resurgent currents by delaying inactivation. Our results support this hypothesis. FHF2B increased resurgent current, shifted the voltage dependence of inactivation to positive potentials, and enhanced channel recovery. FHF2B's inability to mediate long-term inactivation while shifting inactivation to positive potentials likely increased the accessibility of the putative open-channel blocker. The faster recovery observed with overexpression of FHF2B supports this possibility, since recovery when the channel undergoes open-channel block is reported to occur in a shorter time scale than channel recovery from fast inactivation [46] . An alternative explanation is that FHF2B displaces the endogenous negative regulation exerted by FHF2A because all FHFs are predicted to bind to a conserved region in C-terminus of VGSCs [18] . FHF2A is expressed in neurons of all size classes and is particularly predominant in small diameter neurons [48] . The transfected neurons examined in these studies were mostly in the small diameter range. Therefore, it is plausible that displacement of endogenous FHF2A by exogenous FHF2B contributes to some extent to FHF2B's positive regulation of fast resurgent currents.
Based on previous reports, the potential mechanism for FHF2A negative regulation is competition of the long-term inactivation particle with the Navβ4 open-channel blocker [3, 57] . The results from FHF2A and Navβ4 chimeras partially support this hypothesis; however, the implications of the results obtained with these chimeric proteins are limited by a few caveats. Our assumption was that by replacing the peptide sequence of long-term inactivation with the open-channel blocker and vice versa, the activity would be retained in the resulting chimera. However, the β4(F2A) chimera failed to delay channel recovery and produced a very mild enhancement in accumulation of inactivated states, suggesting that the long-term inactivation particle is not fully functional in the β4(F2A) chimeric construct. Therefore, the reduction in resurgent current observed with the expression of the β4(F2A) chimera is likely due to a dominant negative effect of an inactive Navβ4. In a similar manner, there are two possible contributions to F2A(β4)'s resurgent current enhancement: (1) the Navβ4 open-channel blocker sequence is active in the chimera and (2) loss of the long-term inactivation particle allowed other changes in the voltage dependence to favor the endogenous open-channel blocker interaction as seen with FHF2B. To further explore the first possibility, we tested the F2A(β4) chimera in a Nav1.5 HEK cell line that does not generate resurgent current unless the β4 peptide is introduced. We found that indeed the F2A(β4) chimera mediated resurgent currents (Supplementary Fig. S2 ) in the Nav1.5 cell line. This result favors the possibility that F2A(β4) chimera retains open-channel blocker activity. However, it would be simplistic to assume that the resurgent current enhancement is only due to this activity. It is likely a combined effect of removing a limiting determinant (i.e., long-term inactivation particle), adding an active open-channel blocker sequence and the shift in voltage dependence of inactivation contributing to the overall enhancement of resurgent current. Overall, results from β4(F2A) and F2A(β4) chimeras confirmed that regions of the N-terminus of FHF2A and the C-terminus of Navβ4 are important modulators of fast resurgent currents.
FHFs binding to C-terminus of VGSC can cause changes in the biophysical properties of the VGSC [76] . Expression of FHF2A, FHF2B, or F2A(β4) shifted the voltage-dependent inactivation to positive potentials. Since the F2A(β4) chimera lacks the long-term inactivation particle sequence yet retained the ability to cause shifts in voltage dependence of activation and inactivation, the results suggest that these modulations are mainly an effect of the FHF2 core region binding to the Cterminus of Nav1.6. The shift of inactivation to positive potentials is consistent with previous reports of FHF2 binding to the C-terminus of different sodium channels including Nav1.6 [18, 48, 60, 63] . FHF2A and F2A(β4) also shifted activation to positive potentials. Since both F2A(β4) and FHF2A but not FHF2B exerted this effect, it most likely that the N-terminus region that is conserved between F2A(β4) and FHF2A is responsible for this effect.
Interestingly, the chimeras generated for this study might serve as valuable tools for the study of resurgent currents in the future. The β4(F2A) chimera did not significantly alter the voltage dependence of activation or inactivation, recovery from inactivation, or current density. The main effect we detected was a significant reduction in resurgent current. As such, overexpression of this protein in animal models or in vitro studies might serve as a tool to selectively target attenuation of resurgent currents. On the other hand, the F2A(β4) chimera might serve as a tool to artificially induce fast resurgent currents. The applications for the F2A(β4) might be limited since it alters other channel properties. However, we envisioned that the F2A(β4) chimera might be useful in high-throughput assays to identify compounds that might inhibit resurgent currents.
Overall, our data suggest that FHF2A and FHF2B modulate resurgent currents in DRG neurons. The importance of this finding is more evident when we examine how these proteins are regulated in a radicular pain model induced by localized inflammation of the DRG. Our results show that after inflammation, FHFA isoforms are downregulated in acutely isolated neurons, whereas FHF2B was upregulated. We speculate that changes in expression of these isoforms likely contribute to the increased resurgent current generation and hyperexcitability reported in this model [69, 71, 72] . The limitation of the antibody specificity precludes us from definitively contributing the effect solely to changes in the FHF2A isoform. However, the high conservation of the long-term inactivation particle between all FHFAs suggests that if other FHFAs were to interact with Nav1.6, they will likely have a similar negative regulation on resurgent currents. Indeed, we find that the FHFA peptide is able to reduce sensory neuron action potential firing and the enhanced spontaneous activity that is observed in acutely isolated neurons following localized inflammation of the DRG. FHF modulation might also contribute to other pain pathologies. For example, two studies using cDNA arrays reported FHF2 cDNA levels downregulated with no change in FHF1 and FHF4 after peripheral nerve injury [35, 65] . Using Expression Atlas [45] from European Bioinformatics Institute and European Molecular Biology Laboratory, we found that FHF1 and FHF2 levels are downregulated in DRG neurons after spinal nerve ligation, a chronic pain model. Data corresponded to a RNAseq study by Hammer et al. [23] . Which of the FHF1 and FHF2 isoforms contribute most to these changes is unknown. Our study suggests that FHFs might prove to be novel targets for regulating fast resurgent current in DRG neurons and further study might provide new insight into possible therapeutic strategies for pain.
